CoChat

Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life

Bruttomesso, D., Pianta, A., Crazzolara, D., Scaldaferri, E., Lora, L., Guarneri, G., Mongillo, A., Gennaro, R., Miola, M., Moretti, M., Confortin, L., Beltramello, G. P., Pais, M., Baritussio, A., Casiglia, E., Tiengo, A. · 2002 · Diabetic Medicine
Cited by 83

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Aim To study the effect of continuous subcutaneous insulin infusion (CSII) on metabolic control and well‐being in patients with Type 1 diabetes. Methods Efficacy, safety and interference with everyday life associated with CSII were studied retrospectively in 138 diabetic patients from the Veneto region treated for 7.4 ± 0.4 years. Results Glycosylated haemoglobin decreased during the first year of CSII from 9.3 ± 0.2% to 7.9 ± 0.1% (P < 0.0001), and then remained unchanged. Serious hypoglycaemia decreased from 0.31 ± 0.07/year to 0.09 ± 0.02/year (P < 0.003), as did ketoacidosis (from 0.41 ± 0.12/year to 0.11 ± 0.03/year, P < 0.013). During the first year of therapy daily insulin requirement decreased from 49 ± 1 to 42 ± 2 U/day (P < 0.0001) and did not change thereafter. The number of out‐patient consultations and hospital admissions per year also decreased significantly. CSII was associated with a progressive increase of body weight (P < 0.05) and with 0.2 ± 0.04 infections/patient per year at the infusion site. Infection was rated as mild in 72%, moderate in 18%, severe in 10%. Patients reported that CSII improved metabolic control (71%), sense of well‐being (41%), and allowed more freedom (40%). Quality of life, assessed using the DQOL, after 7 years of CSII was rated as good by patients (score of 73.0 ± 1.8 on a scale from 0 to 100). Conclusions This retrospective analysis suggests that CSII improves metabolic control in Type 1 diabetic patients, reduces hypoglycaemic and ketoacidotic events, is well accepted, allows a good quality of life and decreases out‐patient consultations and hospital admissions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-5491.2002.00750.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 83

Metadata

Authors
Bruttomesso, D., Pianta, A., Crazzolara, D., Scaldaferri, E., Lora, L., Guarneri, G., Mongillo, A., Gennaro, R., Miola, M., Moretti, M., Confortin, L., Beltramello, G. P., Pais, M., Baritussio, A., Casiglia, E., & Tiengo, A.
Venue
Diabetic Medicine
Publisher
Wiley
Published
2002-07-30
Volume
19
Issue
8
Pages
628-634
ISSN
  • 0742-3071 (ISSN-L)
  • 1464-5491
OpenAlex
W1976457244
Cited by
83
References
3
FWCI
2.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. https://app.cochat.ai/papers/10.1046/j.1464-5491.2002.00750.x
The paper
Bruttomesso, D., Pianta, A., Crazzolara, D., Scaldaferri, E., Lora, L., Guarneri, G., Mongillo, A., Gennaro, R., Miola, M., Moretti, M., Confortin, L., Beltramello, G. P., Pais, M., Baritussio, A., Casiglia, E., & Tiengo, A. (2002). Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabetic Medicine. https://doi.org/10.1046/j.1464-5491.2002.00750.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.